{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:17:29Z","timestamp":1791307049892,"version":"4.3.1"},"reference-count":22,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with mantle cell lymphoma (MCL) may present with either nodal or leukemic disease. The molecular determinants underlying this different biologic behavior are not known. This study compared the pattern of genetic abnormalities in patients with nodal and leukemic phases of MCL using comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) for specific gene loci. Although both leukemic and nodal MCL showed similar genomic patterns of losses (involving 6q, 11q22-q23, 13q14, and 17p13) and gains (affecting 3q and 8q), genomic loss of chromosome 8p occurred more frequently in patients with leukemic disease (79% versus 11%,P\u2009&amp;lt;\u2009.001). Subsequent CGH analysis confirmed the genomic loss of 8p21-p23 in 6 of 8 MCL cell lines. Interestingly,MYC gene amplification was restricted to cases with 8p deletion. These data indicate the presence of a novel tumor suppressor gene locus on 8p, whose deletion may be associated with leukemic dissemination and poor prognosis in patients with MCL.<\/jats:p>","DOI":"10.1182\/blood.v98.12.3479","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:40Z","timestamp":1027759600000},"page":"3479-3482","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":77,"title":["Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma"],"prefix":"10.1182","volume":"98","author":[{"given":"Jose A.","family":"Martinez-Climent","sequence":"first","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Vizcarra","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Sanchez","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blesa","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Marugan","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Benet","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327esc","family":"Sole","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Rubio-Moscardo","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Terol","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Climent","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sarsotti","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tormo","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Andreu","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Salido","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Ruiz","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J. S.","family":"Dyer","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u0131\u0301a-Conde","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Medical Oncology, Hospital Cl\u0131\u0301nico, University of Valencia, Spain; Laboratory of Hematologic Cytology, Department of Pathology, Hospital del Mar, Barcelona, Spain; Section of Hematology, Gandia Hospital, Gandia, Spain; Institute of Human Genetics, University Hospital Kiel, Germany; and Department of Haematology, University of Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221441580800_B1","first-page":"115","article-title":"Mantle-cell lymphoma.","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol."},{"key":"2020021221441580800_B2","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood."},{"key":"2020021221441580800_B3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues.","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol."},{"key":"2020021221441580800_B4","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases.","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood."},{"key":"2020021221441580800_B5","first-page":"78","article-title":"Mantle cell lymphoma: a lymphoproliferative disorder associated with aberrant function of the cell cycle.","volume":"10(suppl 2)","author":"Garcia-Conde","year":"1996","journal-title":"Leukemia."},{"key":"2020021221441580800_B6","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood."},{"key":"2020021221441580800_B7","first-page":"4608","article-title":"Alterations of cyclin D1\u2013p16-pRB pathway in mantle cell lymphoma.","volume":"57","author":"Dreyling","year":"1997","journal-title":"Cancer Res."},{"key":"2020021221441580800_B8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U","article-title":"Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma.","volume":"21","author":"Monni","year":"1998","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021221441580800_B9","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.","volume":"93","author":"Bea","year":"1999","journal-title":"Blood."},{"key":"2020021221441580800_B10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.0.CO;2-M","article-title":"t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.","volume":"27","author":"Bentz","year":"2000","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021221441580800_B11","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood.V93.4.1372","article-title":"Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features.","volume":"93","author":"Cuneo","year":"1999","journal-title":"Blood."},{"key":"2020021221441580800_B12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas.","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood."},{"key":"2020021221441580800_B13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/A:1008242729509","article-title":"Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas.","volume":"9","author":"Siebert","year":"1998","journal-title":"Ann Oncol."},{"key":"2020021221441580800_B14","volume-title":"The Leukemia-Lymphoma Cell Line FactsBook.","author":"Drexler","year":"2001"},{"key":"2020021221441580800_B15","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0002-9440(10)64140-5","article-title":"Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.","volume":"158","author":"Hernandez","year":"2001","journal-title":"Am J Pathol."},{"key":"2020021221441580800_B16","first-page":"71","article-title":"Splenic marginal zone B-cell lymphoma: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.","volume":"86","author":"Sole","year":"2000","journal-title":"Hematologica."},{"key":"2020021221441580800_B17","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood.V91.3.984","article-title":"Application of interphase fluorescent in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.","volume":"91","author":"Siebert","year":"1998","journal-title":"Blood."},{"key":"2020021221441580800_B18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)65166-8","article-title":"DNA copy number losses in human neoplasms.","volume":"155","author":"Knuutila","year":"1999","journal-title":"Am J Pathol."},{"key":"2020021221441580800_B19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.","volume":"89","author":"Ott","year":"1997","journal-title":"Blood."},{"key":"2020021221441580800_B20","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1038\/sj.onc.1202838","article-title":"Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p.","volume":"18","author":"Sunwoo","year":"1999","journal-title":"Oncogene."},{"key":"2020021221441580800_B21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.1996.5421085.x","article-title":"Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.","volume":"93","author":"Zoldan","year":"1996","journal-title":"Br J Haematol."},{"key":"2020021221441580800_B22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.leu.2401599","article-title":"c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.","volume":"13","author":"Hernandez","year":"1999","journal-title":"Leukemia."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/12\/3479\/1678786\/h8230103479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/12\/3479\/1678786\/h8230103479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T21:49:46Z","timestamp":1581544186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/12\/3479\/53198\/Loss-of-a-novel-tumor-suppressor-gene-locus-at"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.12.3479","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12,1]]}}}